Brief: Aeterna Zentaris Announces EMA Decision To Accept Modification To Agreed Pediatric Investigation Plan For Macimorelin
07/04/2020 18:03
April 7 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS ANNOUNCES EMA DECISION TO ACCEPT A
MODIFICATION
TO AN AGREED PEDIATRIC INVESTIGATION PLAN FOR MACIMORELIN
Source text for Eikon: ID:nGNXf8WQC
Further company coverage: AEZS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update